Conversation with The Cancer LetterRegulatory News FDA’s Harpreet Singh: Overall survival data tells the full story of immune checkpoint inhibitor benefit in NSCLCPooled analysis finds correlations between early endpoints and OS in ICI trials March 15, 2024Vol.50 No.11By Matthew Bin Han Ong and Paul Goldberg
Regulatory News ODAC gives thumbs-up to imetelstat for MDS, upholding the value of transfusion independence March 15, 2024Vol.50 No.11By Jacquelyn Cobb and Paul Goldberg
White House Biden’s FY25 budget requests $522M increase for NCI, $1.5B for ARPA-H, $2.9B for Moonshot March 15, 2024Vol.50 No.11By Alexandria Carolan
Guest Editorial How to navigate early clinical development and support robust registrational strategy and late-stage development in oncology March 15, 2024Vol.50 No.11By Tanja Obradovic
In Brief Leo Mascarenhas named director of Pediatric Hematology & Oncology at Cedars-Sinai Guerin Children’s March 15, 2024Vol.50 No.11
In Brief Aleksandar Sekulic named director of dermatology and translational research at City of Hope Phoenix March 15, 2024Vol.50 No.11
